Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nurix Therapeutics, Inc. | Director, 10%+ Owner | Director Stock Option (right to buy) | 17.5K | May 6, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SEPN | Septerna, Inc. | Oct 24, 2024 | 0 | $0 | 3 | Oct 24, 2024 | Director |
RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Director |
NRIX | Nurix Therapeutics, Inc. | May 6, 2021 | 1 | $0 | 4 | May 24, 2021 | Director, 10%+ Owner |